Presumed pre- or perinatal arterial ischemic stroke

Risk factors and outcomes

Meredith Golomb, Daune L. MacGregor, Trish Domi, Derek C. Armstrong, Brian W. McCrindle, Supriya Mayank, Gabrielle A. Deveber

Research output: Contribution to journalArticle

212 Citations (Scopus)

Abstract

A subgroup of children with arterial ischemic stroke in the pre- or perinatal period present with delayed diagnosis. We identified 22 children who met the following criteria: (1) normal neonatal neurological history, (2) hemiparesis and/or seizures first recognized after two months of age, and (3) computed tomography or magnetic resonance imaging showing remote cerebral infarct. Laboratory evaluations included protein C, protein S, antithrombin, activated protein C resistance screen (APCR), Factor V Leiden (FVL), prothrombin gene defect, methylene tetrahydrofolate reductase variant (MTHFR), anticardiolipin antibody (ACLA), and lupus anticoagulant. Not all children received all tests. Age at last visit ranged from 8 months to 16.5 years (median 4 years). Twelve were boys. Fourteen had left hemisphere infarcts. Median age at presentation was 6 months. Eighteen had gestational complications. Fourteen children had at least transient coagulation abnormalities (ACLA = 11, ACLA + APCR = 1, APCR = 2 with FVL + MTHFR = 1); six of these children had family histories suggestive of thrombosis. Cardiac echocardiogram was unremarkable in the 15 tested. Outcomes included persistent hemiparesis in 22; speech, behavior, or learning problems in 12; and persistent seizures in five, with no evidence of further stroke in any patient. The persistence and importance of coagulation abnormalities in this group need further study.

Original languageEnglish (US)
Pages (from-to)163-168
Number of pages6
JournalAnnals of Neurology
Volume50
Issue number2
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Activated Protein C Resistance
Stroke
Methylenetetrahydrofolate Reductase (NADPH2)
Anticardiolipin Antibodies
Paresis
Seizures
Antithrombin Proteins
Lupus Coagulation Inhibitor
R Factors
Delayed Diagnosis
Protein S
Prothrombin
Protein C
Thrombosis
Tomography
Magnetic Resonance Imaging
Learning
Genes
factor V Leiden

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Golomb, M., MacGregor, D. L., Domi, T., Armstrong, D. C., McCrindle, B. W., Mayank, S., & Deveber, G. A. (2001). Presumed pre- or perinatal arterial ischemic stroke: Risk factors and outcomes. Annals of Neurology, 50(2), 163-168. https://doi.org/10.1002/ana.1078

Presumed pre- or perinatal arterial ischemic stroke : Risk factors and outcomes. / Golomb, Meredith; MacGregor, Daune L.; Domi, Trish; Armstrong, Derek C.; McCrindle, Brian W.; Mayank, Supriya; Deveber, Gabrielle A.

In: Annals of Neurology, Vol. 50, No. 2, 2001, p. 163-168.

Research output: Contribution to journalArticle

Golomb, M, MacGregor, DL, Domi, T, Armstrong, DC, McCrindle, BW, Mayank, S & Deveber, GA 2001, 'Presumed pre- or perinatal arterial ischemic stroke: Risk factors and outcomes', Annals of Neurology, vol. 50, no. 2, pp. 163-168. https://doi.org/10.1002/ana.1078
Golomb M, MacGregor DL, Domi T, Armstrong DC, McCrindle BW, Mayank S et al. Presumed pre- or perinatal arterial ischemic stroke: Risk factors and outcomes. Annals of Neurology. 2001;50(2):163-168. https://doi.org/10.1002/ana.1078
Golomb, Meredith ; MacGregor, Daune L. ; Domi, Trish ; Armstrong, Derek C. ; McCrindle, Brian W. ; Mayank, Supriya ; Deveber, Gabrielle A. / Presumed pre- or perinatal arterial ischemic stroke : Risk factors and outcomes. In: Annals of Neurology. 2001 ; Vol. 50, No. 2. pp. 163-168.
@article{7dbf1ff5bf204c0da2287cd4557481b5,
title = "Presumed pre- or perinatal arterial ischemic stroke: Risk factors and outcomes",
abstract = "A subgroup of children with arterial ischemic stroke in the pre- or perinatal period present with delayed diagnosis. We identified 22 children who met the following criteria: (1) normal neonatal neurological history, (2) hemiparesis and/or seizures first recognized after two months of age, and (3) computed tomography or magnetic resonance imaging showing remote cerebral infarct. Laboratory evaluations included protein C, protein S, antithrombin, activated protein C resistance screen (APCR), Factor V Leiden (FVL), prothrombin gene defect, methylene tetrahydrofolate reductase variant (MTHFR), anticardiolipin antibody (ACLA), and lupus anticoagulant. Not all children received all tests. Age at last visit ranged from 8 months to 16.5 years (median 4 years). Twelve were boys. Fourteen had left hemisphere infarcts. Median age at presentation was 6 months. Eighteen had gestational complications. Fourteen children had at least transient coagulation abnormalities (ACLA = 11, ACLA + APCR = 1, APCR = 2 with FVL + MTHFR = 1); six of these children had family histories suggestive of thrombosis. Cardiac echocardiogram was unremarkable in the 15 tested. Outcomes included persistent hemiparesis in 22; speech, behavior, or learning problems in 12; and persistent seizures in five, with no evidence of further stroke in any patient. The persistence and importance of coagulation abnormalities in this group need further study.",
author = "Meredith Golomb and MacGregor, {Daune L.} and Trish Domi and Armstrong, {Derek C.} and McCrindle, {Brian W.} and Supriya Mayank and Deveber, {Gabrielle A.}",
year = "2001",
doi = "10.1002/ana.1078",
language = "English (US)",
volume = "50",
pages = "163--168",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Presumed pre- or perinatal arterial ischemic stroke

T2 - Risk factors and outcomes

AU - Golomb, Meredith

AU - MacGregor, Daune L.

AU - Domi, Trish

AU - Armstrong, Derek C.

AU - McCrindle, Brian W.

AU - Mayank, Supriya

AU - Deveber, Gabrielle A.

PY - 2001

Y1 - 2001

N2 - A subgroup of children with arterial ischemic stroke in the pre- or perinatal period present with delayed diagnosis. We identified 22 children who met the following criteria: (1) normal neonatal neurological history, (2) hemiparesis and/or seizures first recognized after two months of age, and (3) computed tomography or magnetic resonance imaging showing remote cerebral infarct. Laboratory evaluations included protein C, protein S, antithrombin, activated protein C resistance screen (APCR), Factor V Leiden (FVL), prothrombin gene defect, methylene tetrahydrofolate reductase variant (MTHFR), anticardiolipin antibody (ACLA), and lupus anticoagulant. Not all children received all tests. Age at last visit ranged from 8 months to 16.5 years (median 4 years). Twelve were boys. Fourteen had left hemisphere infarcts. Median age at presentation was 6 months. Eighteen had gestational complications. Fourteen children had at least transient coagulation abnormalities (ACLA = 11, ACLA + APCR = 1, APCR = 2 with FVL + MTHFR = 1); six of these children had family histories suggestive of thrombosis. Cardiac echocardiogram was unremarkable in the 15 tested. Outcomes included persistent hemiparesis in 22; speech, behavior, or learning problems in 12; and persistent seizures in five, with no evidence of further stroke in any patient. The persistence and importance of coagulation abnormalities in this group need further study.

AB - A subgroup of children with arterial ischemic stroke in the pre- or perinatal period present with delayed diagnosis. We identified 22 children who met the following criteria: (1) normal neonatal neurological history, (2) hemiparesis and/or seizures first recognized after two months of age, and (3) computed tomography or magnetic resonance imaging showing remote cerebral infarct. Laboratory evaluations included protein C, protein S, antithrombin, activated protein C resistance screen (APCR), Factor V Leiden (FVL), prothrombin gene defect, methylene tetrahydrofolate reductase variant (MTHFR), anticardiolipin antibody (ACLA), and lupus anticoagulant. Not all children received all tests. Age at last visit ranged from 8 months to 16.5 years (median 4 years). Twelve were boys. Fourteen had left hemisphere infarcts. Median age at presentation was 6 months. Eighteen had gestational complications. Fourteen children had at least transient coagulation abnormalities (ACLA = 11, ACLA + APCR = 1, APCR = 2 with FVL + MTHFR = 1); six of these children had family histories suggestive of thrombosis. Cardiac echocardiogram was unremarkable in the 15 tested. Outcomes included persistent hemiparesis in 22; speech, behavior, or learning problems in 12; and persistent seizures in five, with no evidence of further stroke in any patient. The persistence and importance of coagulation abnormalities in this group need further study.

UR - http://www.scopus.com/inward/record.url?scp=0034899191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034899191&partnerID=8YFLogxK

U2 - 10.1002/ana.1078

DO - 10.1002/ana.1078

M3 - Article

VL - 50

SP - 163

EP - 168

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 2

ER -